Grant: Operating Grant
University of Alberta
$83,634.00
Quantifying bias in randomized controlled trials in child health
EF 2010-11
Résumé
Randomized controlled trials are considered the gold standard for research to show whether a treatment works. However, randomized trials can be biased - that is, they may exaggerate the effectiveness of a treatment. In 2008, a new tool was developed that assesses the risk of bias of randomized trials. This tool helps to show how closely the results of a trial represent the true effectiveness of a treatment. If a trial has a high level of bias, then the results may exaggerate the benefits of a treatment, or even suggest that a treatment helps when in fact, it may be harmful. Previous research showed that studies with high risk of bias exaggerate the effectiveness of a treatment compared with low risk studies. A number of factors can cause bias including how the study was designed, conducted, or reported. Another source of bias is inappropriate influence of a study sponsor (e.g., a drug company), which can result in exaggerated results in favour of the sponsor. This study will provide information on how much we can trust the results of research done on children. It will also provide information to help improve future research in this important population. This information has important implications to make decisions about which treatments will have the best health outcomes for children.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
224810
Name
Hartling Lisa A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Knowledge Mobilization Science
Projecttitle
Quantifying bias in randomized controlled trials in child health
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$83,634
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Bias; Child Health; Meta-Epidemiology; Randomized Controlled Trials
Abstract
Randomized controlled trials are considered the gold standard for research to show whether a treatment works. However, randomized trials can be biased - that is, they may exaggerate the effectiveness of a treatment. In 2008, a new tool was developed that assesses the risk of bias of randomized trials. This tool helps to show how closely the results of a trial represent the true effectiveness of a treatment. If a trial has a high level of bias, then the results may exaggerate the benefits of a treatment, or even suggest that a treatment helps when in fact, it may be harmful. Previous research showed that studies with high risk of bias exaggerate the effectiveness of a treatment compared with low risk studies. A number of factors can cause bias including how the study was designed, conducted, or reported. Another source of bias is inappropriate influence of a study sponsor (e.g., a drug company), which can result in exaggerated results in favour of the sponsor. This study will provide information on how much we can trust the results of research done on children. It will also provide information to help improve future research in this important population. This information has important implications to make decisions about which treatments will have the best health outcomes for children.
Competitiondate
201103
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hartling, Lisa A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $83,634~ $0~